Results 171 to 180 of about 94,250 (267)

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson. [PDF]

open access: yesNPJ Precis Oncol
Lim JU   +15 more
europepmc   +1 more source

Barriers to publishing early phase clinical trials: the oncologists' perspective. [PDF]

open access: yesOncologist
Lucassen MJJ   +23 more
europepmc   +1 more source

A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers. [PDF]

open access: yesCancer
Ahmed J   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy